Bibliografie tematiche / Interleukin-6 / Articoli di riviste

Articoli di riviste sul tema "Interleukin-6"

Segui questo link per vedere altri tipi di pubblicazioni sul tema: Interleukin-6.
Autore: Grafiati
Pubblicato: 4 giugno 2021
Ultima modifica: 11 settembre 2023

Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili

Scegli il tipo di fonte:

Vedi i top-50 articoli di riviste per l'attività di ricerca sul tema "Interleukin-6".

Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.

Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.

Vedi gli articoli di riviste di molte aree scientifiche e compila una bibliografia corretta.

1

&NA;. "Interleukin-3/interleukin-6". Reactions Weekly &NA;, n. 550 (maggio 1995): 11. http://dx.doi.org/10.2165/00128415-199505500-00035.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
2

&NA;. "Interleukin-6". Reactions Weekly &NA;, n. 570 (settembre 1995): 9. http://dx.doi.org/10.2165/00128415-199505700-00023.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
3

Lotz, Martin. "Interleukin-6". Cancer Investigation 11, n. 6 (gennaio 1993): 732–42. http://dx.doi.org/10.3109/07357909309046948.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
4

&NA;. "Interleukin 6". Inpharma Weekly &NA;, n. 877 (marzo 1993): 2. http://dx.doi.org/10.2165/00128413-199308770-00001.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
5

&NA;. "Interleukin 6". Reactions Weekly &NA;, n. 505 (giugno 1994): 8. http://dx.doi.org/10.2165/00128415-199405050-00037.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
6

&NA;. "Interleukin 6". Reactions Weekly &NA;, n. 531 (dicembre 1994): 8. http://dx.doi.org/10.2165/00128415-199405310-00027.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
7

Song, Mingchen, e John A. Kellum. "Interleukin-6". Critical Care Medicine 33, Suppl (dicembre 2005): S463—S465. http://dx.doi.org/10.1097/01.ccm.0000186784.62662.a1.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
8

CASTELL, JOSé V., TILO ANDUS, DIETER KUNZ e PETER C. HEINRICH. "Interleukin-6". Annals of the New York Academy of Sciences 557, n. 1 (28 giugno 2008): 87–101. http://dx.doi.org/10.1111/j.1749-6632.1989.tb24001.x.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
9

LEE, FRANK, CHOY-PIK CHIU, JANUSZ WIDEMAN, PHILLIP HODGKIN, SUSAN HUDAK, LOUISE TROUTT, THERESA NG et al. "Interleukin-6". Annals of the New York Academy of Sciences 557, n. 1 (28 giugno 2008): 215–29. http://dx.doi.org/10.1111/j.1749-6632.1989.tb24015.x.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
10

CLARK, STEVEN C. "Interleukin-6". Annals of the New York Academy of Sciences 557, n. 1 (28 giugno 2008): 438–43. http://dx.doi.org/10.1111/j.1749-6632.1989.tb24036.x.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
11

Olencki, Thomas, James Finke e Ronald M. Bukowski. "Interleukin-6". Clinical Immunotherapeutics 2, n. 4 (ottobre 1994): 278–94. http://dx.doi.org/10.1007/bf03258528.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
12

Sin, Don D., e S. F. Paul Man. "Interleukin-6". Chest 133, n. 1 (gennaio 2008): 4–6. http://dx.doi.org/10.1378/chest.07-2085.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
13

Delk, Nikki A., e Mary C. Farach-Carson. "Interleukin-6". Autophagy 8, n. 4 (aprile 2012): 650–63. http://dx.doi.org/10.4161/auto.19226.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
14

Matsuda, Tadashi, e Toshio Hirano. "Interleukin 6 (IL-6)". Biotherapy 2, n. 4 (ottobre 1990): 363–73. http://dx.doi.org/10.1007/bf02170085.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
15

Rivera-Chavez, Fernando A., Dixie L. Peters-Hybki, Robert C. Barber e Grant E. O'Keefe. "Interleukin-6 Promoter Haplotypes and Interleukin-6 Cytokine Responses". Shock 20, n. 3 (settembre 2003): 218–23. http://dx.doi.org/10.1097/00024382-200309000-00004.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
16

Ridker, Paul M. "Targeting Interleukin-1 and Interleukin-6". Journal of the American College of Cardiology 76, n. 15 (ottobre 2020): 1774–76. http://dx.doi.org/10.1016/j.jacc.2020.08.052.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
17

NORTHEMANN, WOLFGANG, TODD A. BFUCIAK, MASAHIRA HATTORI e GEORG H. FEY. "Rat Interleukin-6". Annals of the New York Academy of Sciences 557, n. 1 (28 giugno 2008): 536–39. http://dx.doi.org/10.1111/j.1749-6632.1989.tb24057.x.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
18

Schneider, Kirsten, Reinhard Klaas, Bernd Kaspers e Peter Staeheli. "Chicken interleukin-6". European Journal of Biochemistry 268, n. 15 (1 agosto 2001): 4200–4206. http://dx.doi.org/10.1046/j.1432-1327.2001.02334.x.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
19

Tamura, T., N. Udagawa, N. Takahashi, C. Miyaura, S. Tanaka, Y. Yamada, Y. Koishihara, Y. Ohsugi, K. Kumaki e T. Taga. "Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6." Proceedings of the National Academy of Sciences 90, n. 24 (15 dicembre 1993): 11924–28. http://dx.doi.org/10.1073/pnas.90.24.11924.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
20

Ogawa, Michio, Kiyoshi Sakamoto, Seiji Mita, Takatoshi Ishiko e Saburo Hisano. "INTERLEUKIN-6 AND SOLUBLE INTERLEUKIN-6 RECEPTOR IN SURGICAL TRAUMA". Shock 4, Supplement (dicembre 1995): 11. http://dx.doi.org/10.1097/00024382-199512001-00045.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
21

De Filippo, G., D. Rendina, F. Moccia, V. Rocco e A. Campanozzi. "Interleukin-6, soluble interleukin-6 receptor/interleukin-6 complex and insulin resistance in obese children and adolescents". Journal of Endocrinological Investigation 38, n. 3 (23 settembre 2014): 339–43. http://dx.doi.org/10.1007/s40618-014-0176-4.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
22

Oka, Masaaki, Hiroshi Kusanagi, Toshihiro Saeki, Norio Iizuka, Hiroto Hayashi, Akira Tangoku, Takuo Murakami e Takashi Suzuki. "Interleukin-6 Production and Interleukin-6 Receptor Expression in Human Esophageal Cancer Cell Lines". Japanese Journal of Gastroenterological Surgery 26, n. 11 (1993): 2707. http://dx.doi.org/10.5833/jjgs.26.2707.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
23

Prens, Errol P., Klazina Benne, Jozef van Damme, Marleen Bakkus, Karin Brakel, Robbert Benner e Theodoor van Joost. "Interleukin-1 and Interleukin-6 in Psoriasis". Journal of Investigative Dermatology 95, n. 6 (dicembre 1990): S121—S124. http://dx.doi.org/10.1111/1523-1747.ep12874991.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
24

Bota, Rafaqat, e Mushtaq Ahmed. "The pathophysiological profile of interleukin-6 and anti-interleukin-6 antibody". El Mednifico Journal 1, n. 2 (6 luglio 2013): 51. http://dx.doi.org/10.18035/emj.v1i2.26.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
25

Ridker, Paul M., e Manas Rane. "Interleukin-6 Signaling and Anti-Interleukin-6 Therapeutics in Cardiovascular Disease". Circulation Research 128, n. 11 (28 maggio 2021): 1728–46. http://dx.doi.org/10.1161/circresaha.121.319077.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
Abstract (sommario):
IL (interleukin)-6 is a pivotal cytokine of innate immunity, which enacts a broad set of physiological functions traditionally associated with host defense, immune cell regulation, proliferation, and differentiation. Following recognition of innate immune pathways leading from the NLRP3 (NOD-, LRR-, and pyrin domain-containing protein 3) inflammasome to IL-1 to IL-6 and on to the hepatically derived clinical biomarker CRP (C-reactive protein), an expanding literature has led to understanding of the proatherogenic role for IL-6 in cardiovascular disease and thus the potential for IL-6 inhibition as a novel method for vascular protection. In this review, we provide an overview of the mechanisms by which IL-6 signaling occurs and how that impacts upon pharmacological inhibition; describe murine models of IL-6 and atherogenesis; summarize human epidemiological data outlining the utility of IL-6 as a biomarker of vascular risk; outline genetic data suggesting a causal role for IL-6 in systemic atherothrombosis and aneurysm formation; and then detail the potential role of IL-6 inhibition in stable coronary disease, acute coronary syndromes, heart failure, and the atherothrombotic complications associated with chronic kidney disease and end-stage renal failure. Finally, we review anti-inflammatory and antithrombotic findings for ziltivekimab, a novel IL-6 ligand inhibitor being developed specifically for use in atherosclerotic disease and poised to be tested formally in a large-scale cardiovascular outcomes trial focused on individuals with chronic kidney disease and elevated levels of CRP, a population at high residual atherothrombotic risk, high residual inflammatory risk, and considerable unmet clinical need.
26

Jucker, M., H. Abts, W. Li, R. Schindler, H. Merz, A. Gunther, C. von Kalle, M. Schaadt, T. Diamantstein e AC Feller. "Expression of interleukin-6 and interleukin-6 receptor in Hodgkin's disease". Blood 77, n. 11 (1 giugno 1991): 2413–18. http://dx.doi.org/10.1182/blood.v77.11.2413.2413.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
Abstract (sommario):
Abstract Interleukin-6 (IL-6) is a multipotent lymphokine that can mediate differentiation of B cells into Ig-secreting cells, stimulate the growth of plasmacytomas, hybridomas, and T cells, and induce acute- phase proteins in liver cells. It has been suggested that IL-6 is involved in the pathogenesis of several diseases by autocrine or paracrine pathways. To examine whether IL-6 is possibly involved in the pathophysiology of Hodgkin's disease (HD), we analyzed the expression of IL-6 and IL-6 receptor mRNA and protein in cell lines and primary specimens from patients with HD. IL-6-specific transcripts were detected in three of six HD-derived cell lines by Northern blot analysis. In the culture supernatants of four HD-derived cell lines, IL- 6 was detected by radioimmunoassay. Biologic activity of IL-6 was confirmed by proliferation of an IL-6-dependent cell line. In situ hybridization experiments showed IL-6-specific transcripts in Hodgkin (H) and Reed-Sternberg (RS) cells in primary tissues of two patients. In addition, mRNAs specific for the IL-6 receptor were detected in five HD-derived cell lines. Immunostaining experiments showed expression of IL-6 receptor molecules on H and RS cells in 8 of 16 cases with HD. Thus, our data suggest that IL-6 might be involved in the pathophysiology of HD.
27

Jucker, M., H. Abts, W. Li, R. Schindler, H. Merz, A. Gunther, C. von Kalle, M. Schaadt, T. Diamantstein e AC Feller. "Expression of interleukin-6 and interleukin-6 receptor in Hodgkin's disease". Blood 77, n. 11 (1 giugno 1991): 2413–18. http://dx.doi.org/10.1182/blood.v77.11.2413.bloodjournal77112413.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
Abstract (sommario):
Interleukin-6 (IL-6) is a multipotent lymphokine that can mediate differentiation of B cells into Ig-secreting cells, stimulate the growth of plasmacytomas, hybridomas, and T cells, and induce acute- phase proteins in liver cells. It has been suggested that IL-6 is involved in the pathogenesis of several diseases by autocrine or paracrine pathways. To examine whether IL-6 is possibly involved in the pathophysiology of Hodgkin's disease (HD), we analyzed the expression of IL-6 and IL-6 receptor mRNA and protein in cell lines and primary specimens from patients with HD. IL-6-specific transcripts were detected in three of six HD-derived cell lines by Northern blot analysis. In the culture supernatants of four HD-derived cell lines, IL- 6 was detected by radioimmunoassay. Biologic activity of IL-6 was confirmed by proliferation of an IL-6-dependent cell line. In situ hybridization experiments showed IL-6-specific transcripts in Hodgkin (H) and Reed-Sternberg (RS) cells in primary tissues of two patients. In addition, mRNAs specific for the IL-6 receptor were detected in five HD-derived cell lines. Immunostaining experiments showed expression of IL-6 receptor molecules on H and RS cells in 8 of 16 cases with HD. Thus, our data suggest that IL-6 might be involved in the pathophysiology of HD.
28

Plenz, Gabriele, Heike Eschert, Michael Erren, Thomas Wichter, Michael Böhm, Markus Flesch, Hans H. Scheld e Mario C. Deng. "The interleukin-6/interleukin-6-receptorsystem is activated in donor hearts". Journal of the American College of Cardiology 39, n. 9 (maggio 2002): 1508–12. http://dx.doi.org/10.1016/s0735-1097(02)01791-6.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
29

Nancey, Stéphane, Nadim Hamzaoui, Driffa Moussata, Ivan Graber, Jacques Bienvenu e Bernard Flourie. "Serum Interleukin-6, Soluble Interleukin-6 Receptor and Crohn’s Disease Activity". Digestive Diseases and Sciences 53, n. 1 (5 giugno 2007): 242–47. http://dx.doi.org/10.1007/s10620-007-9849-6.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
30

Angelis, Pela, Simon Scharf, Alastair Mander, Frank Vajda e Nicholas Christophidis. "Serum interleukin-6 and interleukin-6 soluble receptor in Alzheimer's disease". Neuroscience Letters 244, n. 2 (marzo 1998): 106–8. http://dx.doi.org/10.1016/s0304-3940(98)00136-0.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
31

Rezai, Ali R., Ahmad Rezai, Otoniel Mart�nez-Maza, Meta Vander-Meyden e Martin H. Weiss. "Interleukin-6 and interleukin-6 receptor gene expression in pituitary tumors". Journal of Neuro-Oncology 19, n. 2 (giugno 1994): 131–35. http://dx.doi.org/10.1007/bf01306454.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
32

MONTERO-JULIAN, F. A., E. GAUTHEROT, J. WIJDENES, B. KLEIN e H. BRAILLY. "Pharmacokinetics of Interleukin-6 During Therapy with Anti-Interleukin-6 Monoclonal Antibodies: Enhanced Clearance of Interleukin-6 by a Combination of Three Anti-Interleukin-6 Antibodies". Journal of Interferon Research 14, n. 5 (ottobre 1994): 301–2. http://dx.doi.org/10.1089/jir.1994.14.301.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
33

KENIS, G., C. TEUNISSEN, R. DEJONGH, E. BOSMANS, H. STEINBUSCH e M. MAES. "STABILITY OF INTERLEUKIN 6, SOLUBLE INTERLEUKIN 6 RECEPTOR, INTERLEUKIN 10 AND CC16 IN HUMAN SERUM". Cytokine 19, n. 5 (settembre 2002): 228–35. http://dx.doi.org/10.1016/s1043-4666(02)91961-7.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
34

Kenis, Gunter, Charlotte Teunissen, Raf De Jongh, Eugène Bosmans, Harry Steinbusch e Michael Maes. "STABILITY OF INTERLEUKIN 6, SOLUBLE INTERLEUKIN 6 RECEPTOR, INTERLEUKIN 10 AND CC16 IN HUMAN SERUM". Cytokine 19, n. 5 (settembre 2002): 228–35. http://dx.doi.org/10.1006/cyto.2002.1961.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
35

HIRANO, TOSHIO. "Interleukin 6 (IL-6) and disease." Japanese Journal of Clinical Immunology 13, n. 5 (1990): 444–45. http://dx.doi.org/10.2177/jsci.13.444.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
36

Van Wagoner, N. J., e E. N. Benveniste. "Interleukin-6 regulation in human astrocytes: Synergy between TNF-alpha, interleukin-6, and the soluble-interleukin-6 receptor-alpha". Journal of Neuroimmunology 90, n. 1 (settembre 1998): 53. http://dx.doi.org/10.1016/s0165-5728(98)91497-7.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
37

Hoejberg, Lise, Lars Bastholt e Henrik Schmidt. "Interleukin-6 and melanoma". Melanoma Research 22, n. 5 (ottobre 2012): 327–33. http://dx.doi.org/10.1097/cmr.0b013e3283543d72.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
38

Rose-John, Stefan. "Interleukin-6 Family Cytokines". Cold Spring Harbor Perspectives in Biology 10, n. 2 (15 giugno 2017): a028415. http://dx.doi.org/10.1101/cshperspect.a028415.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
39

Tanaka, Toshio, Masashi Narazaki e Tadamitsu Kishimoto. "Interleukin (IL-6) Immunotherapy". Cold Spring Harbor Perspectives in Biology 10, n. 8 (4 agosto 2017): a028456. http://dx.doi.org/10.1101/cshperspect.a028456.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
40

Suzuki, Kenshi, Akiko Miyashita, Yasuyuki Inoue, Seiko Iki, Hidetoshi Enomoto, Yuji Takahashi e Tamiko Takemura. "Interleukin-6-Producing Pheochromocytoma". Acta Haematologica 85, n. 4 (1991): 217–19. http://dx.doi.org/10.1159/000204897.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
41

Kerr, Ron, David Stirling e Christopher A. Ludlam. "Interleukin 6 and Haemostasis". British Journal of Haematology 115, n. 1 (ottobre 2001): 3–12. http://dx.doi.org/10.1046/j.1365-2141.2001.03061.x.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
42

Sehgal, Pravinkumar B. "Interleukin-6: Molecular Pathophysiology". Journal of Investigative Dermatology 94, n. 6 (giugno 1990): s2—s6. http://dx.doi.org/10.1111/1523-1747.ep12874963.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
43

Van Snick, Jacques. "Interleukin-6: An Overview". Annual Review of Immunology 8, n. 1 (aprile 1990): 253–78. http://dx.doi.org/10.1146/annurev.iy.08.040190.001345.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
44

Pedersen, Bente Klarlund, Adam Steensberg e Peter Schjerling. "Exercise and interleukin-6". Current Opinion in Hematology 8, n. 3 (maggio 2001): 137–41. http://dx.doi.org/10.1097/00062752-200105000-00002.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
45

Patarca, Roberto, e Mary Ann Fletcher. "Interleukin-6 and Disease". Journal of Chronic Fatigue Syndrome 4, n. 1 (gennaio 1998): 53–69. http://dx.doi.org/10.1300/j092v04n01_07.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
46

SEHGAL, PRAVIN B., LING WANG, RAVI RAYANADE, HENG PAN e LOLA MARGULIES. "Interleukin-6-Type Cytokinesa". Annals of the New York Academy of Sciences 762, n. 1 (17 dicembre 2006): 1–14. http://dx.doi.org/10.1111/j.1749-6632.1995.tb32309.x.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
47

Mehra, Reena. "Soluble Interleukin 6 Receptor". Archives of Internal Medicine 166, n. 16 (18 settembre 2006): 1725. http://dx.doi.org/10.1001/archinte.166.16.1725.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
48

Henkin, Robert I., Loren Schmidt e Irina Velicu. "Interleukin 6 in Hyposmia". JAMA Otolaryngology–Head & Neck Surgery 139, n. 7 (1 luglio 2013): 728. http://dx.doi.org/10.1001/jamaoto.2013.3392.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
49

Tesch, H., M. Jüjcler, S. Klein, H. Abts, A. Güjnther, G. R. F. Krueger e V. Diehl. "Hodgkin and Reed-Sternberg Cells Express Interleukin 6 and Interleukin 6 Receptors". Leukemia & Lymphoma 7, n. 4 (gennaio 1992): 297–303. http://dx.doi.org/10.3109/10428199209049781.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
50

Peters, Malte, Guido Blinn, Thomas Jostock, Peter Schirmacher, Karl–Hermann Meyer Zum Büschenfelde, Peter R. Galle e Stefan Rose–John. "Combined interleukin 6 and soluble interleukin 6 receptor accelerates murine liver regeneration". Gastroenterology 119, n. 6 (dicembre 2000): 1663–71. http://dx.doi.org/10.1053/gast.2000.20236.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
Ti possono interessare anche gli elenchi di altri tipi di fonti sul tema "Interleukin-6":
Tesi Libri

Vai alla bibliografia